Tumor Treating Fields (TTFields) In GEneral Routine clinical care in patients with pleural mesothelioma (TIGER Meso)

被引：0
|
作者：
Metzenmacher, Martin [1 ]
Grohe, Christian [2 ]
Ploenes, Till [3 ]
Grosso, Federica [4 ]
Ceresoli, Giovanni [5 ]
机构：
[1] Univ Klinikum Essen, Essen, Germany
[2] Johannesstift Diakonie, Berlin, Germany
[3] Fachkrankenhaus Coswig, Coswig, Germany
[4] Osped Alessandria, Alessandria, Italy
[5] Humanitas Gavazzeni, Bergamo, Italy
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
574
引用
收藏
页码：218 / 218
页数：1
相关论文
共 50 条
  • [41] TTFIELDS IN ROUTINE CLINICAL CARE OF NEWLY DIAGNOSED GBM PATIENTS IN GERMANY - FIRST REPORT ON THE FULLY ENROLLED TIGER STUDY POPULATION
    Baehr, Oliver
    Tabatabai, Ghazaleh
    Fietkau, Rainer
    Goldbrunner, Roland
    Glas, Martin
    NEURO-ONCOLOGY, 2020, 22 : 59 - 59
  • [42] Quality of life of patients with newly diagnosed glioblastoma during TTFields therapy in routine clinical care: first results of the TIGER study
    Baehr, Oliver
    Tabatabai, Ghazaleh
    Fietkau, Rainer
    Goldbrunner, Roland
    Glas, Martin
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 46 - 47
  • [43] QUALITY OF LIFE OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA DURING TTFIELDS THERAPY IN ROUTINE CLINICAL CARE: FIRST RESULTS OF THE TIGER STUDY
    Baehr, O.
    Tabatabai, G.
    Fietkau, R.
    Goldbrunner, R.
    Glas, M.
    NEURO-ONCOLOGY, 2021, 23 : 41 - 42
  • [44] QUALITY OF LIFE OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA DURING TTFIELDS THERAPY IN ROUTINE CLINICAL CARE: FIRST RESULTS OF THE TIGER STUDY
    Baehr, Oliver
    Tabatabai, Ghazaleh
    Fietkau, Rainer
    Goldbrunner, Roland
    Glas, Martin
    NEURO-ONCOLOGY, 2021, 23 : 189 - 190
  • [45] The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts
    Nancy Ann Oberheim-Bush
    Wenyin Shi
    Michael W. McDermott
    Alexander Grote
    Julia Stindl
    Leonardo Lustgarten
    Journal of Neuro-Oncology, 2022, 158 : 453 - 461
  • [46] REPORT ON THE COMBINATION OF AXITINIB AND TUMOR TREATING FIELDS (TTFIELDS) IN THREE PATIENTS WITH RECURRENT GLIOBLASTOMA
    Schulz, Ellina
    Kessler, Almuth F.
    Weiland, Judith
    Linsenmann, Thomas
    Ernestus, Ralf-Ingo
    Hagemann, Carsten
    Loehr, Mario
    NEURO-ONCOLOGY, 2019, 21 : 16 - 16
  • [47] FIRST SAFETY ANALYSIS OF ANAPLASTIC MENINGIOMA PATIENTS TREATED WITH TUMOR TREATING FIELDS (TTFIELDS)
    Mawrin, Christian
    NEURO-ONCOLOGY, 2020, 22 : 56 - 56
  • [48] The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts
    Oberheim-Bush, Nancy Ann
    Shi, Wenyin
    McDermott, Michael W.
    Grote, Alexander
    Stindl, Julia
    Lustgarten, Leonardo
    JOURNAL OF NEURO-ONCOLOGY, 2022, 158 (03) : 453 - 461
  • [49] Effects of tumor treating fields (TTFields; 150 kHz) and cisplatin or pemetrexed combination therapy on mesothelioma cells in vitro and in vivo
    Munster, M.
    Gotlib, K.
    Schneiderman, R. S.
    Porat, Y.
    Voloshin, T.
    Davidi, S.
    Shteingauz, A.
    Kaynan, N.
    Zeevi, E.
    Giladi, M.
    Kirson, E. D.
    Weinberg, U.
    Kinzel, A.
    Palti, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [50] Tumor treating fields (TTFields) for spinal metastasis: Clinical trial concept for use of conductive implants as waveguides to enhance TTFields strength
    Tatsui, Claudio E.
    Carlson, Kristen W.
    Patel, Chirag B.
    CANCER RESEARCH, 2024, 84 (06)
12345